PETS Petmed Express Inc

Price (delayed)

$27.46

Market cap

$558.79M

P/E Ratio

20.19

Dividend/share

$1.16

EPS

$1.36

Enterprise value

$447M

Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct ...

Highlights
The quick ratio has grown by 33% from the previous quarter and by 17% YoY
PETS's P/E is 9% below its last 4 quarters average of 22.1
Petmed Express's EPS has decreased by 11% QoQ and by 3.5% YoY
The company's net income fell by 11% QoQ and by 3.6% YoY

Key stats

What are the main financial stats of PETS
Market
Shares outstanding
20.35M
Market cap
$558.79M
Enterprise value
$447M
Valuations
Price to earnings (P/E)
20.19
Price to book (P/B)
3.97
Price to sales (P/S)
1.89
EV/EBIT
12.69
EV/EBITDA
11.85
EV/Sales
1.53
Earnings
Revenue
$292.32M
EBIT
$35.22M
EBITDA
$37.74M
Free cash flow
$48.09M
Per share
EPS
$1.36
Free cash flow per share
$2.39
Book value per share
$6.92
Revenue per share
$14.54
TBVPS
$8.58
Balance sheet
Total assets
$173.32M
Total liabilities
$32.98M
Debt
$0
Equity
$140.35M
Working capital
$115.32M
Liquidity
Debt to equity
0
Current ratio
4.62
Quick ratio
3.58
Net debt/EBITDA
-2.96
Margins
EBITDA margin
12.9%
Gross margin
29.1%
Net margin
9.3%
Operating margin
11.5%
Efficiency
Return on assets
15.9%
Return on equity
19.6%
Return on invested capital
122%
Return on capital employed
24.9%
Return on sales
12%
Dividend
Dividend yield
4.22%
DPS
$1.16
Payout ratio
85.3%

PETS stock price

How has the Petmed Express stock price performed over time
Intraday
2.5%
1 week
-4.55%
1 month
-2.73%
1 year
-7.6%
YTD
-14.35%
QTD
-13.78%

Financial performance

How have Petmed Express's revenue and profit performed over time
Revenue
$292.32M
Gross profit
$84.94M
Operating income
$33.57M
Net income
$27.26M
Gross margin
29.1%
Net margin
9.3%
The company's net income fell by 11% QoQ and by 3.6% YoY
The operating income is down by 11% from the previous quarter
PETS's net margin is down by 6% since the previous quarter
The company's operating margin fell by 6% QoQ

Growth

What is Petmed Express's growth rate over time

Valuation

What is Petmed Express stock price valuation
P/E
20.19
P/B
3.97
P/S
1.89
EV/EBIT
12.69
EV/EBITDA
11.85
EV/Sales
1.53
Petmed Express's EPS has decreased by 11% QoQ and by 3.5% YoY
PETS's P/E is 9% below its last 4 quarters average of 22.1
The price to book (P/B) is 24% lower than the 5-year quarterly average of 5.2 and 17% lower than the last 4 quarters average of 4.8
The equity is up by 6% year-on-year
The P/S is 14% below the 5-year quarterly average of 2.2 and 14% below the last 4 quarters average of 2.2
The revenue has contracted by 5% from the previous quarter and by 2.7% YoY

Efficiency

How efficient is Petmed Express business performance
The ROIC has grown by 16% YoY and by 3.1% from the previous quarter
The company's return on assets fell by 14% YoY and by 12% QoQ
PETS's ROE is down by 12% from the previous quarter and by 11% YoY
Petmed Express's return on sales has decreased by 6% QoQ

Dividends

What is PETS's dividend history
DPS
$1.16
Dividend yield
4.22%
Payout ratio
85.3%
Recent dividends

Financial health

How did Petmed Express financials performed over time
The quick ratio has grown by 33% from the previous quarter and by 17% YoY
The current ratio has grown by 29% from the previous quarter
PETS's debt is 100% smaller than its equity
The equity is up by 6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.